BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:mRNA is no longer just a headline\, it's transforming medicine
 . From BioNTech's acquisition of CureVac to the EMA's and MHRA's latest g
 uidance on mRNA product development\, and even the world's first personal
 ised CRISPR therapy for Baby KJ\, the field has reached a new level of st
 ability while opening doors to revolutionary therapeutic and gene editing
  applications.\n\nReturning for its fifth year\, the mRNA-Based Therapeut
 ics Summit Europe gives you the insights and connections to turn these br
 eakthroughs into action. The new Gene Editing Focus Day highlights how mR
 NA enables safer\, transient editing strategies\, while addressing regula
 tory and translational challenges. Hear directly from Moderna\, AstraZene
 ca\, CybernaX Bio\, Avocet Bio\, and others about clinical readiness and 
 delivery innovations bringing therapies closer to patients.\n\nWith exclu
 sive investor presentations and a high-profile panel featuring Innosuisse
 \, NRW.Bank\, and Lukasiewicz-PORT\, you'll gain candid perspectives on w
 hat makes an mRNA platform fundable in 2026\, and actionable strategies t
 o de-risk your programs and secure partnerships in today's competitive la
 ndscape.\n\nBuilt around case studies and never-before-seen preclinical a
 nd clinical data on mRNA delivery\, stability\, and next-generation modal
 ities such as saRNA and circRNA\, the summit unites 170+ senior leaders a
 cross R and D\, CMC\, business development\, and regulation for three day
 s of learning\, networking\, and collaboration to put you at the forefron
 t of mRNA and gene editing innovation in 2026.\n\nDate and Time: Tuesday\
 , 27 January 2026 at 08:00 - Thursday\, 29 January 2026 at 17:00\n
DTEND:20260129T170000
DTSTAMP:20260512T220024Z
DTSTART:20260127T080000
LOCATION:Hotel Palace Berlin\, 45 Budapester Straße\, Berlin\, Berlin\, 10
 787\,
SEQUENCE:0
SUMMARY:mRNA is no longer just a headline\, it's transforming medicine. Fr
 om BioNTech's acquisition of CureVac to the EMA's and MHRA's latest guida
 nce on mR...
UID:c235cf75-0b61-46bd-abdc-1fdabb40d40d
END:VEVENT
END:VCALENDAR